Maziar Mike Doustdar
Chief Operating Officer chez NOVO NORDISK A/S
Profil
Actuellement, Maziar Mike Doustdar occupe le poste de vice-président exécutif des opérations internationales chez Novo Nordisk An et de directeur général de Novo Nordisk Health Care AG (une filiale de Novo Nordisk A). M. Doustdar occupait auparavant le poste de vice-président exécutif et chef des opérations internationales chez Novo Nordisk Ltd. Il est titulaire d'un diplôme de premier cycle de l'université Webster.
Postes actifs de Maziar Mike Doustdar
| Sociétés | Poste | Début |
|---|---|---|
| NOVO NORDISK A/S | Chief Operating Officer | 01/09/2016 |
| ORION OYJ | Director/Board Member | 23/03/2022 |
Novo Nordisk Health Care AG
 Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Chief Executive Officer | - |
Anciens postes connus de Maziar Mike Doustdar
| Sociétés | Poste | Fin |
|---|---|---|
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Corporate Officer/Principal | 01/01/2021 |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Chief Operating Officer | - |
Formation de Maziar Mike Doustdar
| Webster University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ORION OYJ | Health Technology |
| Entreprise privées | 3 |
|---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Health Services |
Novo Nordisk Health Care AG
Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
